1-Aminomethyl-6-methoxytetralin (AMMT) is a serotonin reuptake inhibitor (SRI) of the phenethylamine family. It is a cyclized phenethylamine and is an analogue of 1-aminomethyl-5-methoxyindane (AMMI). The drug shows weak affinity for the human serotonin transporter (SERT) (Ki = 7,000–18,000nM). AMMT was first described in the scientific literature by David Lance Roman and David E. Nichols and colleagues at Purdue University by 2004.
See also Cyclized phenethylamine 1-Aminomethyl-5-methoxyindane (AMMI) 9-Aminomethyl-9,10-dihydroanthracene (AMDA) 2CB7 (2C-B-5-hemiFLY-β7)
References
External links AMMT - Isomer Design